NCT03107819View on ClinicalTrials.gov

Metabolomics for Biomarker Discovery in Children With EoE

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Eosinophilic Esophagitis
Interventions
DIAGNOSTIC_TEST

Plasma and urine metabolomics

Through the use of high-pressure liquid chromatography and mass spectrometry, quantitative measurements of targeted metabolites associated with amino acids, methylation, acetylation and the tricarboxylic acid (TCA) cycle will be analyzed on the blood and urine specimens.

Trial Locations (1)

77030

University of Texas Health Science Center, Houston

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

lead

The University of Texas Health Science Center, Houston

OTHER

NCT03107819 - Metabolomics for Biomarker Discovery in Children With EoE | Biotech Hunter | Biotech Hunter